RxDoctor Payments DataLook up a doctor →

Philip Denny, NP

Nurse Practitioner · Henrico, VANPI 1891346326

Payments from drug & device makers

$11,565in general payments, 2019–2025

Across 555 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Biogen$1K
  • UCB, Inc.$958
  • SK Life Science, Inc.$625
  • AstraZeneca$563
  • Novartis$500
  • plus $6K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)100$1,554
Biogen55$1,211
UCB, Inc.37$958
SK Life Science, Inc.21$625
AstraZeneca(2 entities)20$563
Novartis28$500
Lundbeck LLC20$397
EMD Serono, Inc.21$385
Harmony Biosciences LLC13$348
Lilly USA, LLC18$306
Johnson & Johnson(2 entities)8$302
Amneal Pharmaceuticals LLC15$262
Biohaven Pharmaceuticals, Inc.10$255
Eisai Inc.10$199
Bristol Myers Squibb12$196
Genentech USA, Inc.8$196
Pfizer9$192
Kyowa Kirin, Inc.10$189
Grifols USA, LLC8$172
Alnylam Pharmaceuticals Inc.9$167
TG Therapeutics, Inc.7$152
Sanofi6$150
Neurelis, Inc.10$143
Mallinckrodt Hospital Products Inc.5$143
Amgen6$132
Argenx US, Inc.5$127
Teva Pharmaceuticals USA, Inc.7$124
Inspire Medical Systems, Inc.1$119
Neurocrine Biosciences, Inc.7$114
Axsome Therapeutics, Inc.5$99
Biohaven Pharmaceutical Holding Company Ltd.4$95
Sunovion Pharmaceuticals Inc.5$84
ANI Pharmaceuticals, Inc.3$76
Jazz Pharmaceuticals Inc.3$75
Acadia Pharmaceuticals Inc4$71
Livanova USA, Inc.3$64
Supernus Pharmaceuticals, Inc.3$61
MDD US Operations, LLC3$60
Sumitomo Pharma America, Inc.4$56
Merz Pharmaceuticals, LLC2$56
Vanda Pharmaceuticals Inc.2$56
Banner Life Sciences, LLC2$50
Impel Pharmaceuticals Inc.3$50
Life Molecular Imaging Ltd1$48
Cycle Pharmaceuticals Inc2$41
Ultragenyx Pharmaceutical Inc.2$38
Collegium Pharmaceutical, Inc.2$38
Otsuka America Pharmaceutical, Inc.2$35
Corium, LLC2$34
Avanir Pharmaceuticals, Inc.2$32
Octapharma USA, Inc.2$28
Springworks Therapeutics, Inc.1$26
Currax Pharmaceuticals LLC2$23
Acorda Therapeutics, Inc1$20
Averitas Pharma Inc.1$19
Catalyst Pharmaceuticals, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17
Avion Pharmaceuticals1$14

How this compares

$11,565 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia →

Medicare billing

Part B allowed, 2024
$60,152
Medicare patients
413
Services billed
651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Henrico

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →